University of Arizona researchers accelerate rare pediatric disease drug repurposing with AWS

At the University of Arizona (U of A) College of Medicine – Phoenix, a translational neuroscience lab of eight researchers is pursuing a mission to find and repurpose existing drugs as potential treatments for rare pediatric disorders. Working with Amazon Web Services (AWS), the team connected four AWS services into an integrated research pipeline, using generative artificial intelligence (AI) and specialized foundation models to turn raw sequencing data into insights that help identify promising drug candidates. In this post, learn how the lab is using generative AI to expand its research cap